Filing Details
- Accession Number:
- 0001654954-19-010741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-13 16:24:04
- Reporting Period:
- 2019-09-11
- Accepted Time:
- 2019-09-13 16:24:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1540159 | Edesa Biotech Inc. | EDSA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1620188 | R. Frank Oakes | C/O Edesa Biotech, Inc. 100 Spy Court Markham A6 L3R 5H6 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2019-09-11 | 1,809 | $5.72 | 6,165 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.
Billionaire Hedge Funds
